Showing results (561-570 of 625) with videos related to
Sort By:
Pageof 63
Molecular Oncology|April 15, 2025
A large-scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression-free survivalEmma J Beddowes, Mario Ortega Duran, Solon Karapanagiotis, et al.NPJ Breast Cancer|June 8, 2021
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancersLeticia De Mattos-Arruda, Javier Cortes, Juan Blanco-Heredia, et al.British Journal of Pharmacology|December 28, 2025
Pharmacological inhibition of hydroxysteroid 11-beta dehydrogenase type 1 (11-βHSD1) after myocardial infarction preserves cardiac function in a translational mini-pig modelSara Al Disi, Raimondo Ascione, Shazia Khan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2026
Predicting neoadjuvant breast cancer therapy response using BRIDGE from tumor transcriptomics and histopathologyT Cantore, D-T Hoang, L R Pal, et al.Cell Reports|May 13, 2025
Fitness and transcriptional plasticity of human breast cancer single-cell-derived clonesLong V Nguyen, Yaniv Eyal-Lubling, Daniel Guerrero-Romero, et al.Elife|October 16, 2019
Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammationAtiqur Rahman, Katherine M Henry, Kimberly D Herman, et al.Nature|December 7, 2021
Multi-omic machine learning predictor of breast cancer therapy responseStephen-John Sammut, Mireia Crispin-Ortuzar, Suet-Feung Chin, et al.Nature Communications|September 14, 2021
DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulationRajbir Nath Batra, Aviezer Lifshitz, Ana Tufegdzic Vidakovic, et al.Science Translational Medicine|August 9, 2019
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancerBradon R McDonald, Tania Contente-Cuomo, Stephen-John Sammut, et al.Nature|March 15, 2019
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroupsOscar M Rueda, Stephen-John Sammut, Jose A Seoane, et al.Pageof 63